Clinical validation of the Abbott RealTime high risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2409-2410

  Hesselink, A T ^a   Meijer, C J L M ^a   Poljak, M ^b   Berkhof, J ^a   Van Kemenade, F J ^a   Van Der Salm, M L ^a   Bogaarts, M ^a   Snijders, P J F ^a   Heideman, D A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER SCREENING; DNA EXTRACTION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; INFECTION RISK; LABORATORY AUTOMATION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL TIME HIGH RISK HUMAN PAPILLOMAVIRUS ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VALIDATION STUDY; VIRUS DETECTION; WART VIRUS; ADULT; CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR DIAGNOSIS; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; VIROLOGY;

EID: 84879456680     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00633-13     Document Type: Article

References (9)

1. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ. 2009. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int. J. Cancer 124:516-520.
2. Meijer CJ, Berkhof H, Heideman DA, Hesselink AT, Snijders PJ. 2009. Validation of high-risk HPV tests for primary cervical screening. J. Clin. Virol. 46(Suppl 3):S1-S4.
3. Heideman DA, Hesselink AT, Berkhof J, van Kemenade F, Melchers WJ, Daalmeijer NF, Verkuijten M, Meijer CJ, Snijders PJ. 2011. Clinical validation of the Cobas 4800 HPV test for cervical screening purposes. J. Clin. Microbiol. 49:3983-3985.
4. Poljak M, Cuzick J, Kocjan BJ, Iftner T, Dillner J, Arbyn M. 2012. Nucleic acid tests for the detection of alpha human papillomaviruses. Vaccine 30(Suppl 5):F100-F106.
5. Arbyn M, Ronco G, Anttile A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. 2012. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30(Suppl 5):F88-F99.
6. Huang S, Tang N, Mak WB, Erickson B, Salituro J, Li Y, Krumpe E, Schneider G, Yu H, Robinson J, Abravaya K. 2009. Principles and analytical performance of Abbott RealTime High Risk HPV test. J. Clin. Virol. 45(Suppl 1):S13-S7.
7. Snijders PJF, Van den Brule AJC, Jacobs MV, Pol RP, Meijer CJLM. 2005. HPV DNA detection and typing in cervical scrapes by general primer GP5+/6+PCR. Methods Mol. Med. 119:101-114.
8. Carozzi FM, Burroni E, Bisanzi S, Puliti D, Confortini M, Giorgi Rossi P, Sani C, Scalisi A, Chini F. 2011. Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting. J. Clin. Microbiol. 49:1446-1451.
9. Poljak M, Ostrbenk A, Seme K, Ucakar V, Hillemanns P, Bokal EV, Jancar N, Klavs I. 2011. Comparison of clinical and analytical performance of the Abbott RealTime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening. J. Clin. Microbiol. 49:1721-1729.